This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
C3_BILIARY_GALLBLADDER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1683 |
4. Check minimum number of eventsNone |
1683 |
5. Include endpoints |
1683 |
6. Filter based on genotype QC (FinnGen only) |
1683 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1683 | 504 | 1179 |
| Unadjusted period prevalence (%) | 0.42 | 0.17 | 0.52 |
| Median age at first event (years) | 72.26 | 71.45 | 72.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1517
- Matched controls
- 15170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
2957.1
323.0
666
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
1923.9
323.0
304
*
130
Kela drug reimbursment
Malignant tumour
14.3
323.0
726
912
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
92.5
323.0
437
66
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
60.6
323.0
387
85
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
326.7
317.6
312
12
Z51.5
ICD-10 Finland
Palliative care
11.1
219.8
457
565
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
954.4
176.8
170
*
N02AA05
ATC
oxycodone; systemic
5.6
170.2
620
1667
A03FA01
ATC
metoclopramide; systemic, rectal
5.4
168.6
641
1807
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
164.6
155
*
198
Kela drug reimbursment
Sorafenib
360.7
161.3
160
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.2
156.4
388
613
K83.1
ICD-10 Finland
Obstruction of bile duct
31.7
150.7
202
73
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
149.5
141
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
514.6
143.9
141
*
UJK02
NOMESCO Finland
ERCP
14.7
128.3
224
177
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
16.2
126.6
212
151
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
21.0
123.4
187
101
JN4CD
NOMESCO Finland
Very extensive body CT
9.8
122.8
265
322
L01XE05
ATC
[U] sorafenib; oral
407.1
115.1
114
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
33.8
114.0
150
49
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
22.1
113.0
168
85
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
24.9
107.0
153
68
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.7
101.8
218
257
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.0
99.5
241
349
K83.0
ICD-10 Finland
Cholangitis
23.6
99.2
144
67
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
93.7
89
*
A04AA02
ATC
granisetron; systemic, transdermal
6.9
92.3
249
420
JLC30
NOMESCO Finland
Pancreatoduodenectomy
56.3
88.7
105
20
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
16.4
85.6
141
94
R18
ICD-10 Finland
Ascites
14.8
83.2
143
106
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.1
80.6
192
267
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
18.7
80.5
126
73
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
80.2
372
1134
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
18.1
80.2
127
76
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.8
80.2
147
126
JN4BD
NOMESCO Finland
Extensive body CT
4.3
79.2
340
964
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
78.8
75
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
786.6
77.0
75
*
H02AB02
ATC
dexamethasone; systemic
4.6
76.0
295
755
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
75.8
239
487
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
46.5
75.2
92
21
L01BC06
ATC
capecitabine; oral
8.4
74.9
173
228
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
14.7
69.4
119
87
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
24.0
68.9
99
44
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
341.4
66.0
66
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
665.8
65.4
64
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
12.2
63.8
119
105
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.5
63.6
158
232
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
62.1
212
468
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
62.0
292
882
C24.00
ICD-10 Finland
Hepatic duct
+∞
61.9
59
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.8
60.2
134
165
C24.09
ICD-10 Finland
Biliary duct or passage NOS
611.4
60.1
59
*
323
Kela drug reimbursment
Sorafenib
314.5
59.7
60
*
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
57.7
55
*
Z94.4
ICD-10 Finland
Liver transplant status
65.6
54.7
63
10
C24.02
ICD-10 Finland
Common bile duct
269.5
51.4
52
*
JN4AD
NOMESCO Finland
Body CT examination
4.0
51.2
226
638
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.4
50.2
160
324
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
48.3
147
281
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
48.2
46
*
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
48.2
46
*
C03DA01
ATC
spironolactone; oral
3.0
48.0
318
1224
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.6
48.0
179
429
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
47.1
539
2845
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
12.1
46.8
87
76
JJC00
NOMESCO Finland
Allogenic transplantation of liver
68.5
46.4
53
8
A05AA02
ATC
ursodeoxycholic acid; oral
15.9
46.2
76
50
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
42.3
45.9
57
14
A09AA02
ATC
multienzymes (lipase, protease etc.)
8.4
45.8
104
132
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
45.0
43
*
D77
ICPC
Malignant digestive neopl other/NOS
25.8
44.4
62
25
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
429.1
42.4
42
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
33.5
42.2
55
17
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
80.9
42.1
47
6
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
94.8
42.0
46
5
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
41.5
197
587
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
22.3
41.2
60
28
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
9.0
41.1
89
104
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
40.8
39
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
14.5
39.9
68
49
A04AA01
ATC
ondansetron; systemic, rectal
4.1
39.4
163
430
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
52.6
38.7
46
9
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
38.7
37
*
R50.9
ICD-10 Finland
Fever, unspecified
2.7
38.1
299
1263
127
Kela drug reimbursment
Transplant complication
13.7
37.9
66
50
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
37.9
409
2054
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
37.7
36
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
40.4
37.6
47
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
35.2
531
3087
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
35.2
282
1202
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
68.3
35.1
40
6
WZC30
NOMESCO Finland
Teaching
2.8
34.6
257
1045
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
16.9
33.9
54
33
A06AD11
ATC
lactulose; oral
2.3
33.8
385
1964
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
24.9
32.8
46
19
B01AB05
ATC
enoxaparin; parenteral
2.1
32.7
520
3071
N02AX02
ATC
tramadol; systemic, rectal
1.9
32.2
708
4729
JJB30
NOMESCO Finland
Excision of two segments of liver
73.5
32.0
36
5
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
115.8
31.8
34
*
K76.9
ICD-10 Finland
Liver disease, unspecified
11.3
30.7
58
53
3019
Kela drug reimbursment
Lenvatinib
308.2
29.9
30
*
JKA20
NOMESCO Finland
Cholecystectomy
4.6
29.4
106
244
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
24.7
29.3
41
17
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
28.8
550
3446
J01MA12
ATC
levofloxacin; systemic
2.1
28.3
368
1975
1508
Kela drug reimbursment
Lenvatinib
286.5
27.8
28
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
14.2
27.7
47
34
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
27.3
108
272
JAH01
NOMESCO Finland
Laparoscopy
4.8
26.8
91
197
L01EX02
ATC
sorafenib; oral
142.5
26.7
28
*
L04AA06
ATC
mycophenolic acid; systemic
9.2
26.6
56
63
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
25.1
24
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
59.1
25.1
29
5
B01AB10
ATC
tinzaparin; parenteral
3.1
25.0
147
509
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
24.9
481
2993
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
21.7
24.8
36
17
A06AH03
ATC
naloxegol; oral
8.8
24.6
53
62
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
10.7
24.4
47
45
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
24.3
215
953
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.8
24.2
70
126
A98
ICPC
Health maint/preventive medicine
0.6
24.2
891
10881
L04AD01
ATC
ciclosporin; systemic
9.4
24.1
50
55
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
24.0
23
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
24.0
23
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
23.9
76
153
A04AA55
ATC
palonosetron, combinations; systemic
8.5
23.7
52
63
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
17.2
23.6
37
22
JAH00
NOMESCO Finland
Laparotomy
4.6
23.4
83
188
UJK12
NOMESCO Finland
Peroral cholangioscopy
28.7
23.2
31
11
I81
ICD-10 Finland
Portal vein thrombosis
25.1
23.1
32
13
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.2
23.0
40
31
L01EX08
ATC
lenvatinib; oral
+∞
23.0
22
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
233.3
22.7
23
*
WW500
NOMESCO Finland
Blood transfusion
3.6
22.4
105
307
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
22.4
407
2457
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
22.4
232
1113
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
17.0
22.3
35
21
WX402
NOMESCO Finland
General anaesthesia
2.3
22.2
230
1101
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
29.5
21.9
29
10
A10BA02
ATC
metformin; oral
1.8
21.9
523
3459
A07AA11
ATC
rifaximin; oral
39.2
21.8
27
7
C03CA01
ATC
furosemide; systemic
1.7
21.2
656
4681
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.9
21.1
70
148
JJB10
NOMESCO Finland
Atypcal resection of liver
21.8
20.8
30
14
JJA20
NOMESCO Finland
Open biopsy of liver
30.5
20.6
27
9
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
42.3
20.5
25
6
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.6
19.5
42
50
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
8.9
19.4
41
47
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
19.4
304
1726
B18.2
ICD-10 Finland
Chronic viral hepatitis C
15.8
19.3
31
20
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
17.0
19.2
30
18
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
15.0
18.9
31
21
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
28.2
18.7
25
9
JJ5AT
NOMESCO Finland
NA
101.3
18.6
20
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
101.3
18.6
20
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.2
18.5
58
116
R4190
NOMESCO Finland
Nutritional therapy
4.4
18.2
67
159
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
17.9
148
630
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.7
17
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.7
17
*
K92.0
ICD-10 Finland
Haematemesis
3.7
17.7
79
223
JJB71
NOMESCO Finland
Laparoscopic resection of liver
96.2
17.6
19
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
18.9
17.3
26
14
176
Kela drug reimbursment
Regorafenib
31.9
17.0
22
7
A10BB12
ATC
glimepiride; oral
2.2
17.0
193
959
D97
ICPC
Liver disease NOS
22.1
16.9
24
11
A02BC02
ATC
pantoprazole; systemic
1.6
16.8
916
7424
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
35.4
16.7
21
6
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
10.2
16.4
32
32
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.6
16.4
57
128
A10AE04
ATC
insulin glargine; parenteral
2.1
15.8
185
928
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
15.8
676
5126
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
60.7
15.8
18
*
R4110
NOMESCO Finland
Physiotherapy
1.7
15.6
385
2520
ZX120
NOMESCO Finland
Intravenous
2.2
15.6
162
772
K72.1
ICD-10 Finland
Chronic hepatic failure
26.6
15.6
21
8
TJA10
NOMESCO Finland
Laparocentesis
19.4
15.6
23
12
XX4BW
NOMESCO Finland
NA
38.5
15.4
19
5
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
8.8
15.2
32
37
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.2
15.1
33
41
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
14.7
255
1491
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
14.6
14
*
SPAT1262
SPAT
Handing over of treatment supplies
1.7
14.0
302
1889
C10AA05
ATC
atorvastatin; oral
0.6
13.9
334
4757
TK800
NOMESCO Finland
Hemodialysis
4.1
13.9
54
136
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.2
13.8
42
82
WX004
NOMESCO Finland
Patient-controlled sedation
11.5
13.8
25
22
XQ902
NOMESCO Finland
Other photography
11.5
13.8
25
22
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.8
13.7
45
96
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
75.8
13.6
15
*
C24.01
ICD-10 Finland
Cystic duct
+∞
13.6
13
*
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
5.5
13.5
39
72
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
8.8
13.0
27
31
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
12.9
88
1767
A10BH01
ATC
sitagliptin; oral
2.0
12.9
176
942
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
12.7
74
256
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
12.7
159
820
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.6
433
3069
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
A41.8
ICD-10 Finland
Other specified sepsis
4.1
12.4
48
121
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.3
12.4
62
194
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
12.1
150
773
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.4
12.0
57
171
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
12.0
369
2542
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
14.8
11.8
19
13
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
11.8
251
1558
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
11.7
259
3781
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
+∞
11.5
11
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
11.5
11
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
120.9
11.4
12
*
B01AF01
ATC
rivaroxaban; oral
0.4
11.3
48
1145
ZXC40
NOMESCO Finland
Use of ultrasound
10.6
11.3
21
20
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.9
11.2
45
118
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
7.1
11.1
26
37
T90
ICPC
Diabetes non-insulin dependent
1.6
11.0
355
2464
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
11.0
78
1551
WX892
NOMESCO Finland
Monitored bed care
2.1
10.9
131
664
205
Kela drug reimbursment
Chronic hypertension
1.5
10.8
542
4152
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
4.8
10.8
35
75
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
28.2
10.7
14
5
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
60.4
10.6
12
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
10.6
188
2900
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
10.6
79
321
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
10.4
10
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.8
10.4
25
37
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.4
10.3
89
389
WX002
NOMESCO Finland
Sedation and analgesia
1.6
10.2
278
1846
J01MA02
ATC
ciprofloxacin; systemic
1.4
10.2
593
4668
B01AB04
ATC
dalteparin; parenteral
2.4
10.0
84
363
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
26.2
9.8
13
5
L01XE21
ATC
[U] regorafenib; oral
20.2
9.8
14
7
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.3
9.8
35
83
SPAT1255
SPAT
Intravenous administration of medicine
2.1
9.8
107
520
SPAT1053
SPAT
Memory test
0.5
9.8
110
1905
R83
ICPC
Respiratory infection other
0.4
9.6
42
990
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
10.1
9.5
18
18
JDE00
NOMESCO Finland
Gastrojejunostomy
15.1
9.5
15
10
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
100.6
9.4
10
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
12.4
9.4
16
13
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
9.3
33
78
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.7
9.3
62
234
A04AD12
ATC
aprepitant; systemic
4.7
9.2
30
65
N02AA01
ATC
morphine; systemic, rectal
3.3
9.1
44
136
K72.9
ICD-10 Finland
Hepatic failure, unspecified
10.1
9.0
17
17
JK3MB
NOMESCO Finland
Postoperative cholangiography
36.9
9.0
11
*
C10AA07
ATC
rosuvastatin; oral
0.6
8.9
151
2360
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
24.2
8.9
12
5
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
24.2
8.9
12
5
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.2
8.9
44
139
SPAT1109
SPAT
Analgesia with portable analgesic pump
6.9
8.8
21
31
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.8
100
1727
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.5
8.7
69
287
A79
ICPC
Malignancy NOS
3.7
8.6
36
100
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
8.5
191
1199
K92.1
ICD-10 Finland
Melaena
2.0
8.5
105
542
L04AA10
ATC
sirolimus; oral
27.7
8.5
11
*
WX882
NOMESCO Finland
High dependency care
2.7
8.4
57
218
K70.4
ICD-10 Finland
Alcoholic hepatic failure
8.6
8.3
17
20
UJF32
NOMESCO Finland
Coloscopy
1.5
8.2
366
2710
369
Kela drug reimbursment
Regorafenib
14.5
8.2
13
9
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
8.2
8.1
17
21
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
33.5
8.1
10
*
N06DX01
ATC
memantine; oral
0.4
8.1
35
827
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
11.8
8.1
14
12
K75.0
ICD-10 Finland
Abscess of liver
10.1
8.0
15
15
L03AA02
ATC
filgrastim; parenteral
2.8
8.0
48
173
WW200
SPAT
NA
0.3
8.0
19
579
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
8.0
165
1013
L04AX01
ATC
azathioprine; systemic
2.5
7.9
58
235
XF612
NOMESCO Finland
Measurement of central venous pressure
10.9
7.8
14
13
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
7.8
140
824
A10AE05
ATC
insulin detemir; parenteral
2.1
7.7
90
451
K76.89
ICD-10 Finland
Other specified diseases of liver
15.1
7.7
12
8
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
18.4
7.6
11
6
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
25.1
7.6
10
*
WX419
NOMESCO Finland
Other general anesthesy
5.4
7.5
21
39
P20
ICPC
Memory disturbance
0.6
7.5
87
1498
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
7.4
90
459
L01EX05
ATC
regorafenib; oral
80.5
7.4
8
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
13.4
7.4
12
9
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
13.4
7.4
12
9
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.6
7.4
20
36
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
7.3
72
1301
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.1
7.3
78
378
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
1551A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts
+∞
7.3
7
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
7.2
35
795
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
15.8
7.2
11
7
RS220
NOMESCO Finland
NA
4.3
7.2
25
59
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.6
7.2
108
1742
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
7.2
110
612
K51.5
ICD-10 Finland
Left sided colitis
3.2
7.2
36
116
K51.8
ICD-10 Finland
Other ulcerative colitis
4.4
7.1
24
55
K70.1
ICD-10 Finland
Alcoholic hepatitis
5.6
7.1
19
34
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
10.1
7.0
13
13
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
10.1
7.0
13
13
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.9
7.0
21
43
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.2
6.9
20
39
207
Kela drug reimbursment
Chronic arrhythmias
0.6
6.9
122
1896
WX704
NOMESCO Finland
Intubation
2.0
6.9
84
433
XKD00
NOMESCO Finland
Uroflowmetry
0.6
6.8
164
2384
JJB20
NOMESCO Finland
Excision of single segment of liver
16.8
6.7
10
6
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
6.7
32
731
K81.0
ICD-10 Finland
Acute cholecystitis
2.7
6.7
43
162
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
6.6
231
3140
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
6.6
255
3399
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
6.6
72
1260
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
8.7
6.6
13
15
D76
ICPC
Malignant neoplasm pancreas
8.7
6.6
13
15
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.8
6.5
20
42
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
0.3
6.5
17
498
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.7
6.5
197
2740
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
6.2
6.5
16
26
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
6.5
47
192
2BB01
NOMESCO Finland
NA
70.1
6.4
7
*
K85.8
ICD-10 Finland
Other acute pancreatitis
4.9
6.4
19
39
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.2
6.3
18
35
K76.7
ICD-10 Finland
Hepatorenal syndrome
11.1
6.3
11
10
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.6
6.3
42
164
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
6.3
6
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
6.3
6
*
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
JJ2CT
NOMESCO Finland
Biopsy of liver with CT guidance
+∞
6.3
6
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
+∞
6.3
6
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
6.2
232
1647
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
26.8
6.2
8
*
N02BE01
ATC
paracetamol; systemic, rectal
0.8
6.2
951
10467
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
6.2
116
1779
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
6.2
77
1298
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
6.1
41
160
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.2
6.1
21
50
PJD99
NOMESCO Finland
Excision of other lymph nodes
12.6
6.1
10
8
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
6.7
6.0
14
21
E83.1
ICD-10 Finland
Disorders of iron metabolism
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768441) Liver Pathology biopsy report
277
69
47.86
307.65
1.7
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
354
292
15.09
307.65
5.1
3.0
u/ml
847.4
1148.7
0.14
340
274
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
563
532
15.40
307.65
5.5
3.2
u/ml
2168.3
8088.9
0.56
514
447
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
841
1533
9.97
307.65
5.5
3.9
ug/l
35.0
23.6
0.44
763
1299
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
596
1271
6.71
285.39
5.6
2.1
g/l
0.2
0.2
12.11
565
1175
(3023183) Ammonium ion [Moles/volume] in Plasma
295
306
11.48
261.61
4.7
2.4
umol/l
42.6
33.5
4.22
253
249
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
585
1455
5.63
232.10
11.0
2.7
umol/l
30.3
9.9
11.67
546
1278
(3007566) Smooth muscle Ab [Titer] in Serum
246
271
10.46
207.59
1.5
1.2
titre
72.1
92.0
0.38
19
20
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
180
144
13.88
187.39
1.3
1.1
g/l
1.7
1.6
1.24
171
131
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
107
27
42.25
177.26
4.0
2.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
427
1377
3.82
112.65
11.6
6.6
mmol/l
8.5
11.4
12.38
409
1297
(4035726)
367
1083
4.05
109.73
1.7
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
121
126
10.27
105.08
1.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
328
930
4.14
103.23
1.7
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
323
906
4.17
103.16
1.6
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
83
49
17.77
101.07
4.5
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
806
4035
2.91
99.56
6.6
2.4
u/l
59.1
57.5
0.19
775
3719
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
753
3691
2.88
95.91
12.2
3.1
u/l
71.6
35.2
8.81
729
3509
(3023487) Leukocytes [#/volume] in Peritoneal fluid
70
49
14.86
77.90
2.3
2.4
e6/l
793.5
790.9
0.00
54
40
(3024561) Albumin [Mass/volume] in Serum or Plasma
985
5964
2.57
76.70
15.5
4.8
g/l
30.8
34.3
58.66
942
5495
(3042733) HLA Ab [Presence] in Serum
54
25
22.28
73.02
1.4
5.2
—
—
—
0
0
(3024471) HLA-A [Type]
54
26
21.42
71.84
1.0
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
642
3256
2.57
71.75
14.3
4.1
%
76.5
82.3
6.79
623
3177
(3033799) Differential panel - Peritoneal fluid
62
41
15.66
71.08
2.2
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
494
2216
2.74
70.72
5.8
3.1
mmol/l
0.8
0.8
15.66
472
2055
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1061
6813
2.51
70.34
27.0
6.1
umol/l
28.8
12.5
17.60
1034
6435
(3024932) HLA-DR beta [Type]
53
26
21.01
69.95
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
77
78
10.30
67.92
1.7
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
62
46
13.96
66.70
2.2
2.1
e6/l
1293.3
38220.9
0.51
42
29
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
294
1042
3.21
64.07
2.4
1.7
%
1.6
1.6
0.47
265
848
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
314
1173
3.06
62.42
6.8
2.4
u/l
36.6
35.6
0.07
293
978
(3032080) INR in Blood by Coagulation assay
947
6078
2.28
58.44
16.8
11.5
inr
1.3
1.4
2.58
251
1653
(3010375) cycloSPORINE [Mass/volume] in Blood
56
47
12.29
55.90
33.6
27.1
ug/l
136.4
129.9
0.20
46
38
(3044007) Cell count panel - Peritoneal fluid
49
39
12.91
50.49
2.4
2.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
68
88
8.01
49.56
1.3
1.3
titre
87.5
162.9
0.49
16
17
(3023368) Bacteria identified in Blood by Culture
721
4355
2.15
49.13
7.1
4.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
63
83
7.85
45.21
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
63
85
7.66
44.30
2.3
2.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
132
356
3.94
43.23
1.5
1.5
ug/g
167.2
265.4
5.42
75
217
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
84
165
5.31
40.85
1.4
1.4
u/ml
116.1
140.0
—
9
27
(3028026) IgM [Mass/volume] in Serum or Plasma
195
701
3.02
40.61
1.6
1.8
g/l
1.5
1.6
0.27
168
634
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
87
182
4.99
39.38
1.3
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
43
42
10.48
38.77
1.6
1.3
g/l
10.9
14.4
1.39
32
30
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
89
194
4.79
38.37
1.4
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
120
335
3.78
37.36
8.4
3.6
mg/l
1.8
1.8
0.09
108
295
(3044640) Blood type and Crossmatch panel - Blood
657
4144
1.96
36.99
4.0
2.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
81
170
4.96
36.51
1.4
1.2
u/ml
405.1
285.5
1.78
62
93
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
99
246
4.21
36.18
9.4
5.1
iu/ml
963.3
944.8
0.01
35
35
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
382
2009
2.17
35.19
2.7
2.6
%
24.4
22.1
1.73
348
1690
(3005719) IgG [Mass/volume] in Serum or Plasma
217
889
2.65
35.17
2.1
2.7
g/l
12.5
10.7
3.75
191
805
(3042936) Bacteria identified in Isolate by Culture
374
1999
2.12
32.80
2.6
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
91
229
4.14
32.69
1.4
1.2
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
33
29
11.59
31.86
1.2
1.6
g/l
71.5
26.5
0.40
21
24
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
914
11518
0.55
31.10
4.9
5.0
mmol/l
6.5
6.1
8.49
780
10201
(3004789) Transferrin [Mass/volume] in Serum or Plasma
384
2113
2.06
30.96
2.6
2.6
g/l
2.3
2.2
0.19
358
1935
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
235
3.99
30.75
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
927
11619
0.55
30.66
5.2
5.3
mmol/l
2.4
2.5
2.42
784
10433
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
890
11283
0.55
30.61
5.0
4.7
mmol/l
4.2
4.4
3.05
767
10216
(3018677) aPTT in Platelet poor plasma by Coagulation assay
402
2260
2.02
30.49
2.9
2.0
s
31.7
30.2
3.90
394
2189
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
84
212
4.12
30.05
5.8
6.1
mg/l
11.4
12.2
0.69
76
197
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
884
11157
0.56
28.72
4.9
4.7
mmol/l
1.3
1.4
12.91
752
9997
(3022948) Iron [Moles/volume] in Serum or Plasma
401
2299
1.98
28.54
2.6
2.6
umol/l
12.6
12.1
0.58
384
2108
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
509
3159
1.88
28.52
4.0
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
149
569
2.78
27.51
1.3
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
39
53
7.51
27.21
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
39
53
7.51
27.21
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
937
7032
1.75
27.17
11.0
3.1
u/l
233.1
56.0
50.96
880
6414
(3006922) Hepatitis E virus Ab [Presence] in Serum
40
58
7.04
26.36
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
805
5827
1.73
26.22
7.4
4.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
118
415
2.98
25.32
1.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
323
5325
0.51
25.28
3.4
4.7
%
22.3
21.8
0.21
136
2786
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
837
10551
0.59
24.57
4.3
4.5
mu/l
2.5
2.2
1.31
718
9360
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
903
11113
0.60
23.33
8.6
6.6
mmol/mol
43.6
41.1
8.13
788
10084
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
64
160
4.12
23.20
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
144
589
2.58
23.16
3.0
2.6
u/ml
0.3
0.3
0.88
81
344
(3013650) Neutrophils [#/volume] in Blood by Automated count
908
6953
1.66
22.71
20.8
8.7
e9/l
4.5
4.4
0.36
841
6021
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
311
1758
1.94
22.52
3.9
3.9
u/l
251.8
248.9
0.11
299
1647
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
873
10797
0.60
22.49
4.6
4.2
mmol/l
1.4
1.3
2.95
747
9587
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
203
3763
0.48
21.89
2.4
3.3
ug/l
0.7
0.8
1.15
128
2662
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
148
3077
0.43
21.74
1.9
1.6
mmol/l
1.6
1.3
2.23
127
2522
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
151
4.08
21.57
2.0
1.6
g/l
0.7
0.9
0.53
39
119
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
455
6583
0.58
21.55
3.9
5.4
ug/l
2.2
4.4
2.63
357
5813
(3016650) Hepatitis A virus Ab [Presence] in Serum
60
153
4.03
21.19
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
40
74
5.51
20.77
1.1
1.0
mg/l
290.5
295.0
0.10
32
66
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
88
295
3.09
20.52
3.2
2.5
%
223.2
204.8
0.89
88
280
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
157
711
2.33
20.20
2.0
1.8
ug/l
2.7
3.1
0.10
147
614
(3014576) Chloride [Moles/volume] in Serum or Plasma
322
1904
1.85
20.12
9.0
6.6
mmol/l
104.4
104.3
0.06
317
1847
(3003458) Phosphate [Moles/volume] in Serum or Plasma
326
1936
1.85
20.09
7.7
5.5
mmol/l
1.0
1.0
0.36
302
1774
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
645
8461
0.61
19.95
3.9
3.6
pmol/l
14.9
15.1
1.02
552
7455
(4281824)
46
102
4.61
19.44
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
208
1071
2.07
19.43
1.8
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
906
10946
0.63
19.07
39.2
16.9
ml/min/173m2
76.3
72.4
5.65
814
9115
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
375
5543
0.58
18.29
2.5
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
58
162
3.67
18.05
2.1
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
41
89
4.70
17.79
1.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
170
845
2.13
17.38
8.0
7.3
mmol/l
23.6
24.9
3.81
165
835
(3010813) Leukocytes [#/volume] in Blood
1121
12820
0.62
17.28
56.2
26.0
e9/l
7.4
7.0
5.89
1075
12346
(3000963) Hemoglobin [Mass/volume] in Blood
1121
12820
0.62
17.28
56.6
26.1
g/l
121.1
133.2
101.36
1081
12533
(3026361) Erythrocytes [#/volume] in Blood
1121
12818
0.62
17.23
56.1
25.9
e12/l
4.1
4.4
71.49
1073
12343
(3035941) MCH [Entitic mass]
1121
12817
0.62
17.21
55.9
25.8
pg
30.2
30.5
4.00
1082
12531
(3024731) MCV [Entitic volume]
1121
12817
0.62
17.21
56.0
25.8
fl
91.3
91.8
2.78
1084
12533
(3007461) Platelets [#/volume] in Blood
1121
12815
0.62
17.16
56.2
25.9
e9/l
225.1
236.3
3.88
1076
12392
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
402
2693
1.65
15.73
8.6
3.1
mmol/l
2.5
2.5
9.81
377
2344
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
146
715
2.14
15.48
5.4
4.0
mmol/l
22.9
24.1
3.24
138
638
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
162
830
2.05
15.25
10.5
9.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
555
4046
1.55
15.11
5.7
4.0
ph
7.4
7.4
0.69
138
767
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
849
6824
1.49
14.33
9.8
6.8
mmol/l
1.2
1.2
6.01
707
5717
(1761868) Lipid panel - Serum or Plasma
203
3323
0.56
13.60
3.8
3.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
952
7882
1.48
13.52
10.6
5.0
mmol/l
7.4
6.9
7.61
918
7443
(3026782) Osmolality of Urine
414
2889
1.57
13.40
3.4
3.0
mosm/kgh2o
567.0
561.1
0.22
375
2463
(3002032) Base excess in Venous blood by calculation
241
1464
1.75
13.39
5.1
3.7
mmol/l
1.3
2.1
2.47
173
1149
(40762365) Oxygen content in Arterial blood by calculation
21
32
6.63
13.21
3.4
2.8
ml/dl
14.1
14.8
0.46
21
27
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
782
6250
1.47
13.17
8.7
6.1
mmol/l
1.2
1.2
8.45
748
5608
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
84
348
2.49
13.16
2.0
3.3
u/ml
192.6
51.2
1.58
78
334
(3012501) Base excess in Blood by calculation
84
348
2.49
13.16
5.4
4.7
mmol/l
2.0
2.6
1.32
60
236
(3003694) ABO and Rh group [Type] in Blood
411
2890
1.56
12.78
1.5
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
239
1472
1.73
12.61
5.1
3.7
kpa
5.5
5.8
4.18
230
1424
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
243
1505
1.72
12.57
4.9
3.8
—
—
—
0
0
(3002256) Pathology report gross observation
259
1634
1.69
12.51
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
260
1643
1.69
12.48
1.4
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1098
12379
0.67
12.47
32.6
11.1
u/l
43.4
25.4
46.79
1068
11822
(3037522) Nuclear Ab [Titer] in Serum
217
1305
1.76
12.45
1.5
1.3
titre
375.8
481.9
0.73
53
289
(3023103) Potassium [Moles/volume] in Serum or Plasma
1113
12514
0.67
12.44
44.9
21.5
mmol/l
4.0
4.0
0.36
1075
12142
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
23
41
5.67
12.43
1.5
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
211
1267
1.76
12.16
8.9
7.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1113
12493
0.68
12.06
44.8
21.3
mmol/l
137.6
139.6
68.43
1078
12134
(3002173) Hemoglobin [Mass/volume] in Arterial blood
236
1468
1.71
11.99
8.7
7.4
g/l
115.8
120.4
2.94
225
1416
(3027801) Oxygen [Partial pressure] in Arterial blood
279
1814
1.64
11.98
8.1
6.7
kpa
12.8
11.6
4.12
262
1719
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
279
1814
1.64
11.98
8.1
6.7
kpa
4.9
5.1
2.30
263
1719
(3003396) Base excess in Arterial blood by calculation
279
1816
1.64
11.92
8.1
6.7
mmol/l
0.4
1.2
3.00
213
1392
(40758558) Short blood count panel - Blood
424
3044
1.53
11.88
15.9
6.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
255
1634
1.66
11.56
8.4
7.0
%
96.5
95.2
3.08
244
1572
(3015377) Calcium [Moles/volume] in Serum or Plasma
583
4494
1.45
11.38
7.9
3.3
mmol/l
2.3
2.3
2.88
544
3837
(3010421) pH of Blood
90
411
2.26
11.36
5.4
4.4
ph
7.4
7.4
0.55
82
338
(42870588) Differential panel, method unspecified - Blood
553
4228
1.46
11.24
7.2
5.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
100
488
2.12
10.72
8.0
5.7
mmol/l
1.7
1.3
0.97
84
432
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
23
7.01
10.58
1.1
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
158
912
1.81
10.38
1.7
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
78
356
2.25
9.89
9.3
6.2
mmol/l
12.0
11.2
1.06
68
323
(3018572) Chloride [Moles/volume] in Blood
78
356
2.25
9.89
9.3
6.2
mmol/l
106.2
105.3
1.24
68
323
(3007930) Methemoglobin/Hemoglobin.total in Blood
121
652
1.92
9.86
7.2
4.8
%
0.9
0.9
0.34
109
616
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
122
660
1.91
9.83
7.2
4.8
%
1.7
1.7
0.20
112
623
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
25
6.45
9.82
1.1
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1079
12044
0.71
9.77
37.9
17.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
185
1137
1.70
9.77
5.7
3.8
mmol/l
1.2
1.2
3.17
173
986
(3014007) Fractional oxyhemoglobin in Arterial blood
160
947
1.76
9.66
8.5
8.6
%
94.6
93.8
0.99
160
940
(3014111) Lactate [Moles/volume] in Serum or Plasma
208
1323
1.65
9.64
7.1
6.6
mmol/l
2.0
1.4
2.93
196
1262
(3019060) Gas panel - Arterial blood
177
1084
1.71
9.46
6.2
4.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
245
3520
0.64
9.10
1.7
1.6
nmol/l
17.9
19.8
1.55
222
2971
(1616796) Gas panel - Central venous blood
73
349
2.14
8.30
3.6
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
175
1107
1.65
8.27
1.4
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
697
5769
1.36
8.25
8.0
6.0
%
21.7
25.5
14.78
648
5314
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
48
193
2.53
8.11
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
162
1011
1.67
8.07
8.2
6.6
mmol/l
23.4
24.6
3.55
151
945
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
25
70
3.61
7.86
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
155
2.69
7.83
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
526
0.22
7.52
1.5
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
681
5676
1.34
7.48
8.2
6.1
%
9.3
9.0
1.15
635
5265
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
52
231
2.29
7.10
3.1
3.5
%
57.8
60.2
0.52
52
231
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
1043
0.46
6.94
1.5
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
336
0.21
6.93
1.4
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
25
77
3.28
6.84
3.0
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1086
9743
1.32
6.80
28.9
7.5
u/l
185.1
81.0
64.67
1052
9086
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
1627
0.57
6.72
1.2
1.2
iu/ml
75.6
38.5
0.54
33
501
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
24
73
3.32
6.70
1.7
1.5
u/l
5.5
9.2
0.44
17
32
(3022096) Basophils/100 leukocytes in Blood
656
5501
1.32
6.69
8.0
5.8
%
0.5
0.6
4.04
609
5088
(3006504) Eosinophils/100 leukocytes in Blood
672
5657
1.31
6.66
8.0
5.8
%
2.4
2.8
4.99
628
5228
(3004809) Band form neutrophils/100 leukocytes in Blood
55
262
2.14
6.38
2.9
3.9
%
2.4
1.5
0.64
39
199
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
5
18.08
6.26
1.3
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
669
5664
1.30
6.24
7.8
5.8
%
62.3
58.9
9.58
623
5252
(3028271) Lactate [Moles/volume] in Capillary blood
52
246
2.15
6.15
2.4
2.0
mmol/l
2.0
1.7
0.75
52
240
(3002582) Erythrocytes [#/volume] in Urine
523
4289
1.32
6.15
4.1
3.6
e6/l
67.4
95.4
0.64
454
3410
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
118
2.66
5.91
1.0
1.1
u/l
50.7
52.2
0.06
24
78
(3003338) MCHC [Mass/volume]
832
9362
0.78
5.89
50.0
23.6
g/l
330.9
331.7
1.51
817
9248
(3030467) Casts [#/volume] in Urine by Automated count
477
3882
1.32
5.87
4.0
3.4
e6/l
0.9
0.5
1.71
413
3030
(3013707) Erythrocyte sedimentation rate by Westergren method
794
8968
0.78
5.71
4.9
4.1
mm/h
23.8
14.5
23.22
709
8173
(3019198) Lymphocytes [#/volume] in Blood
709
6100
1.28
5.68
7.7
5.7
e9/l
1.4
1.9
11.05
629
5286
(3022217) INR in Platelet poor plasma by Coagulation assay
298
2275
1.38
5.58
20.8
30.2
inr
1.6
1.5
0.27
37
305
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
151
1020
1.53
5.43
4.4
3.1
ml/min/173m2
61.2
59.2
0.22
73
440
(3030905) Polymorphonuclear cells [#/volume] in Blood
46
219
2.13
5.39
2.9
3.2
e9/l
4.4
4.5
0.06
46
219
(3000850) Epithelial cells [#/volume] in Urine
383
3055
1.33
5.37
3.3
2.7
e6/l
5.9
4.2
2.43
357
2706
(40768800) Prostate Pathology biopsy report
12
426
0.28
5.36
1.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
250
1867
1.40
5.34
1.6
1.5
g/l
3.8
2.8
4.91
184
1081
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
142
952
1.54
5.29
9.1
8.5
%
0.7
0.7
0.10
142
945
(36304419) Bacteria [Presence] in Urine
453
3711
1.30
5.23
4.0
3.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
173
1213
1.48
5.20
4.6
3.1
kpa
4.8
4.5
1.00
166
1170
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
99
1544
0.62
5.13
1.1
1.2
u/ml
14.9
14.8
0.00
35
538
(3004775) Volume in Urine collected for unspecified duration
29
117
2.50
4.97
2.2
2.2
ml
843.6
651.4
1.22
15
74
(3006315) Basophils [#/volume] in Blood
690
5990
1.26
4.92
7.8
5.6
e9/l
0.0
0.0
2.96
597
5098
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
56
3.24
4.90
2.6
1.5
u/l
23.2
78.0
—
6
12
(40768804) Tissue Pathology biopsy report
552
4681
1.27
4.77
2.8
2.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
59
322
1.86
4.76
2.9
2.6
%
14.5
15.8
0.73
16
166
(3001604) Monocytes [#/volume] in Blood
685
5966
1.25
4.68
7.8
5.5
e9/l
0.7
0.6
0.95
598
5066
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
5
14.05
4.57
5.9
3.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
11
8.22
4.56
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
25
98
2.57
4.56
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
93
586
1.62
4.55
1.2
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
123
828
1.52
4.52
9.3
8.6
mmol/l
23.5
24.4
2.19
116
760
(3039443) Prostate specific Ag panel - Serum or Plasma
6
242
0.25
4.49
1.0
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
498
5827
0.79
4.43
1.9
2.1
pmol/l
87.4
92.0
1.35
258
3108
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
108
2.43
4.23
1.9
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
150
1067
1.45
4.22
5.1
4.1
%
1.3
0.9
0.72
82
360
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
20
73
2.76
4.19
2.4
3.6
nmol/l
71.5
101.0
1.22
20
73
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
587
5073
1.24
4.19
4.0
3.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
701
6176
1.23
4.17
8.3
5.7
e9/l
0.2
0.2
5.25
613
5353
(3044889) 12 lead EKG panel
789
8742
0.82
4.08
4.8
4.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
60
348
1.75
4.02
1.9
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
136
962
1.45
3.95
9.2
8.4
%
1.3
1.3
0.16
136
955
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
287
2292
1.30
3.91
3.4
3.2
e6/l
2.2
1.7
0.45
201
1334
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
329
1.76
3.89
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
855
9371
0.82
3.86
51.7
21.6
%
15.2
13.9
67.23
840
9119
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
245
1.86
3.72
1.8
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1107
11809
0.82
3.69
41.0
18.0
mg/l
39.0
28.3
17.41
1063
9737
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
316
2577
1.28
3.66
2.0
1.9
—
—
—
0
0
(4010399)
55
908
0.59
3.65
1.2
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
91
2.44
3.64
1.5
1.2
g/l
0.5
0.4
0.37
11
69
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
91
2.44
3.64
1.5
1.2
g/l
3.1
2.9
0.13
11
71
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
91
2.44
3.64
1.5
1.2
g/l
7.6
7.5
0.02
11
70
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
60
359
1.70
3.63
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
60
359
1.70
3.63
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
292
2362
1.29
3.61
5.6
4.5
—
—
—
0
0
(4062490)
22
92
2.41
3.56
1.5
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
20
80
2.52
3.55
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
229
1798
1.32
3.53
2.0
1.8
—
—
—
0
0
(3016750) Collection duration of Urine
21
87
2.43
3.47
2.0
2.1
min
513.6
500.6
0.27
13
61
(3017446) Testosterone [Moles/volume] in Serum or Plasma
65
1010
0.63
3.37
2.2
2.2
nmol/l
11.4
12.5
0.44
50
858
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
358
4227
0.81
3.26
2.1
2.2
u/l
190.9
237.5
0.80
332
3941
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
116
1596
0.71
3.26
3.8
4.7
%
33.3
32.9
0.15
75
1029
(3002179) Metamyelocytes/100 leukocytes in Blood
130
947
1.40
3.25
4.9
4.0
%
0.9
0.6
1.13
59
251
(21494755) Public health laboratory ask at order entry panel
19
421
0.45
3.24
1.3
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
548
4809
1.21
3.19
4.5
4.0
e6/l
74.4
131.3
1.43
468
3615
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
226
1798
1.30
3.17
2.0
1.8
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
19
80
2.39
3.06
1.7
1.6
umol/l
11.3
15.1
2.07
19
75
(3009542) Hematocrit [Volume Fraction] of Blood
947
10175
0.84
3.05
39.9
19.3
%
34.6
38.7
21.80
582
6213
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
161
1.94
3.00
3.0
3.7
%
62.8
57.3
0.45
16
103
(3020891) Body temperature
89
614
1.47
3.00
5.2
4.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
25
120
2.10
2.99
1.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
538
0.53
2.97
1.8
1.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
46
272
1.71
2.96
1.4
1.3
mmol/l
58.4
63.1
0.26
26
222
(3021440) Promyelocytes/100 leukocytes in Blood
134
999
1.37
2.94
5.5
4.2
%
0.1
0.1
0.23
77
330
(3000494) Fungus identified in Specimen by Culture
184
1441
1.31
2.91
1.8
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
30
3.35
2.91
1.2
1.5
—
—
—
0
0
(4094501)
11
291
0.37
2.89
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
11
289
0.38
2.85
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
201
1.81
2.82
1.8
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
58
370
1.59
2.81
2.4
2.4
ug/min
122.0
79.6
0.39
34
227
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
32
3.14
2.65
1.2
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
82
572
1.46
2.64
4.3
3.8
mmol/l
2.1
1.4
1.51
82
562
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
162
1.87
2.63
2.6
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
135
1.94
2.56
1.8
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
413
1.52
2.51
3.6
3.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
108
801
1.37
2.49
3.9
3.3
mmol/l
23.7
25.1
3.14
103
776
(3036603) Volume of Urine
17
76
2.25
2.44
1.4
1.5
ml
1959.5
1598.3
0.64
11
19
(3028308) Erythrocytes [#/volume] in Pleural fluid
37
219
1.70
2.42
1.6
1.4
e6/l
29136.3
91864.5
1.21
24
136
(3005322) IgE [Units/volume] in Serum or Plasma
33
553
0.59
2.41
1.1
1.3
u/ml
212.2
227.9
0.08
27
505
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
12
5.01
2.40
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
307
0.45
2.39
1.6
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
347
0.48
2.39
1.4
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
121
924
1.33
2.33
5.3
4.2
%
0.0
0.4
0.65
62
273
(3007853) Bacteria identified in Skin by Aerobe culture
193
1568
1.26
2.32
1.7
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
37
222
1.68
2.32
2.5
2.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
242
2877
0.81
2.30
4.0
3.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
163
1.79
2.27
2.0
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
13
4.63
2.27
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
18
3.90
2.25
1.1
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
29
3.11
2.22
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
309
0.48
2.19
1.2
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
48
2.51
2.18
1.9
1.4
umol/l
69.0
64.2
—
5
30
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
268
0.44
2.18
1.1
1.2
—
37.2
—
0
11
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
254
0.43
2.17
1.1
1.2
—
4.0
—
0
26
(3034426) Prothrombin time (PT)
9
30
3.01
2.15
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
30
3.01
2.15
1.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
152
0.33
2.14
1.0
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
76
547
1.41
2.13
1.5
1.5
u/ml
3.1
16.9
—
5
11
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
88
2.06
2.11
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
25
138
1.82
2.09
3.4
3.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
31
2.91
2.07
1.1
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
238
1.61
2.05
1.9
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
154
1.77
2.04
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
46
302
1.54
2.04
1.7
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
179
1466
1.25
2.03
3.4
3.2
ng/l
208.8
255.5
1.11
164
1347
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
424
3768
1.17
2.02
2.6
2.3
mg/l
3.6
3.1
2.69
369
3171
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
216
1.63
2.01
1.9
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
38
240
1.60
1.99
1.6
1.5
e6/l
756.5
1604.7
3.25
30
178
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
171
1.71
1.97
2.5
4.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
84
2.03
1.96
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
12
256
0.46
1.95
1.1
1.2
—
3.5
—
0
35
(3009261) Glucose [Presence] in Urine by Test strip
552
6046
0.87
1.94
4.5
4.0
estimate
0.0
0.0
0.50
122
1100
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
27
2.97
1.93
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
27
2.97
1.93
1.4
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
211
1.62
1.92
1.8
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
135
1.79
1.91
1.1
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
544
5956
0.87
1.89
5.8
5.3
estimate
0.0
0.0
0.00
128
1137
(40761536) Microorganisms panel - Urine sediment
133
1063
1.27
1.87
4.4
4.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
53
0.00
1.87
0.0
1.2
—
37.6
—
0
26
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
485
1.40
1.85
1.3
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
34
215
1.59
1.80
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
80
2.01
1.80
1.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
80
2.01
1.80
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
548
5979
0.88
1.79
4.4
3.9
estimate
0.0
0.0
0.00
130
1132
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
192
1.63
1.78
1.7
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
219
0.45
1.77
1.2
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
899
8476
1.13
1.74
5.1
4.9
e6/l
1000.6
1810.8
0.40
16
165
(4034850)
24
395
0.60
1.71
24.0
12.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
196
1.59
1.66
1.8
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
130
1054
1.25
1.65
2.7
2.1
nmol/l
416.0
369.1
1.54
120
947
(3011412) CD3 cells [#/volume] in Blood
17
90
1.90
1.65
1.8
1.9
e9/l
1.1
0.9
0.33
11
52
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
76
1.98
1.64
1.7
2.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
413
0.62
1.62
2.7
3.1
nmol/l
0.7
0.8
1.34
19
319
(1761482) Bacteria [#/volume] in Urine by Culture
58
423
1.38
1.57
4.3
4.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
272
1.48
1.57
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
152
1.65
1.57
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
311
0.57
1.56
1.2
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
33
2.43
1.54
9.9
7.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
153
1.64
1.53
1.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
153
1.64
1.53
1.6
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
274
2407
1.17
1.51
3.3
3.0
e6/l
0.9
1.2
0.93
188
1441
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
184
0.49
1.50
1.0
1.2
—
32.1
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
65
2.01
1.48
2.8
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
321
2860
1.15
1.47
4.1
4.2
ng/l
517.8
360.4
0.27
271
2494
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
140
1676
0.82
1.46
15.1
8.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
22
2.73
1.43
8.0
8.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
88
1.83
1.41
2.6
3.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
29
2.42
1.39
11.1
7.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
665
0.73
1.39
1.1
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
78
990
0.78
1.38
1.7
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
210
0.52
1.37
1.1
1.2
—
2.5
—
0
12
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
406
0.66
1.35
1.3
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
47
2.13
1.33
1.0
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
13
68
1.92
1.33
1.5
1.9
%
79.1
70.4
1.65
13
61
(36660697) Celiac disease serology panel - Serum
54
716
0.75
1.33
1.1
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
152
1.59
1.32
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
24
152
1.59
1.32
1.6
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
129
1.64
1.30
1.3
1.2
u/ml
1.5
6.1
—
10
40
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
440
4783
0.89
1.29
2.7
2.2
nmol/l
72.7
78.0
3.33
400
4136
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
389
0.66
1.28
1.1
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
35
2.29
1.27
1.0
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
22
340
0.64
1.26
1.6
1.6
e6/l
16706.6
18560.2
0.07
13
241
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
116
0.43
1.25
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
729
0.76
1.23
2.4
2.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
289
0.62
1.22
1.3
1.3
mg/l
416.3
555.6
2.12
18
267
(3021788) Differential panel - Synovial fluid
15
252
0.59
1.22
1.3
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
38
2.11
1.18
1.8
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
532
0.73
1.18
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
94
1.71
1.17
1.3
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
11
57
1.94
1.17
3.1
4.6
%
60.1
50.4
1.26
11
52
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
50
2.01
1.16
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
184
0.54
1.14
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
95
1.69
1.14
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
95
1.69
1.14
1.7
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
15
246
0.61
1.13
1.3
1.3
e6/l
0.8
44.1
—
10
196
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
135
1.56
1.11
1.4
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
195
0.56
1.11
1.5
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
73
905
0.80
1.11
3.6
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
293
0.64
1.11
1.3
1.3
—
—
—
0
0
(44790049)
24
160
1.51
1.09
2.0
1.5
—
—
—
0
0
(44790048)
24
160
1.51
1.09
2.0
1.5
—
—
—
0
0
(44790047)
24
160
1.51
1.09
2.0
1.5
—
—
—
0
0
(44806118)
24
160
1.51
1.09
2.0
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
442
4762
0.90
1.09
3.2
3.3
ng/l
1390.9
2013.7
1.87
384
4116
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
128
1.57
1.08
1.4
1.2
u/ml
1.9
5.9
1.55
11
59
(3026008) Bacteria identified in Urine by Culture
451
4184
1.11
1.07
3.1
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
217
0.60
1.06
1.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
22
2.28
1.03
1.8
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
22
2.28
1.03
1.2
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
335
0.68
1.03
1.3
1.5
iu/ml
0.0
17.1
—
6
80
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
59
742
0.79
1.03
1.5
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
34
2.06
1.03
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
188
1.44
1.01
2.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
380
0.71
1.01
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
53
1.89
1.01
1.8
1.2
—
—
—
0
0
(4268621)
15
91
1.65
1.00
2.5
2.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
68
1.77
1.00
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
68
1.77
1.00
1.3
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
92
767
1.21
0.99
1.6
1.8
g/l
1.4
1.5
0.97
77
649
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
21
308
0.68
0.98
1.5
1.8
mg/l
16.4
12.2
0.61
15
282
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
30
0.00
0.97
0.0
1.8
—
14.5
—
0
22
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
31
0.00
0.96
0.0
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
141
1.50
0.95
1.5
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.3
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
125
1.53
0.94
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
125
1.53
0.94
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
125
1.53
0.94
1.3
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
244
0.65
0.92
2.1
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
28
2.15
0.91
2.0
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
159
1.45
0.91
1.6
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
98
831
1.19
0.90
3.1
2.9
e6/l
0.8
0.4
0.61
98
807
(3005570) Glucose [Moles/volume] in Urine
9
153
0.59
0.88
1.7
2.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
105
0.47
0.88
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
43
1.86
0.87
1.5
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
586
5553
1.08
0.86
4.2
4.3
ng/l
37.5
65.7
2.01
483
4355
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
120
1.51
0.85
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
88
746
1.19
0.82
2.4
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
152
1346
1.14
0.82
1.8
2.7
g/l
65.3
66.1
0.46
132
1213
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
97
1129
0.85
0.82
1.2
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.81
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.81
1.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.81
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.81
1.3
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
147
1.43
0.80
1.2
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.0
—
2.1
—
0
11
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
295
1.29
0.78
1.2
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
27
0.00
0.77
0.0
2.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
34
1.77
0.76
1.3
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
53
1.70
0.75
1.3
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
185
0.65
0.75
1.4
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
25
2.00
0.72
1.0
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
109
0.55
0.72
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
miu/ml
1151.2
1442.1
—
5
27
(3019150) Specific gravity of Urine by Refractometry
249
2691
0.91
0.67
5.1
4.3
kg/l
1.0
1.0
0.28
58
420
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
85
736
1.16
0.66
3.0
2.7
%
1.1
1.1
0.28
85
731
(3006270) Folate [Moles/volume] in Blood
18
128
1.41
0.65
1.2
1.3
nmol/l
376.7
339.0
0.21
11
107
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
270
2507
1.09
0.65
2.5
1.7
mg/l
3.0
1.5
3.11
221
1971
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
213
0.70
0.65
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
44
359
1.23
0.64
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
40
323
1.24
0.64
3.6
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
131
0.61
0.63
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
187
2040
0.91
0.62
1.2
1.2
u/ml
2.9
1.6
0.36
28
512
(3044290) Cell count panel - Cerebral spinal fluid
16
222
0.72
0.61
1.1
1.2
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
5
30
1.67
0.61
1.0
1.4
%
49.0
12.3
—
5
22
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
191
1.31
0.61
1.4
1.4
u/l
11.4
7.8
1.00
15
144
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
51
1.57
0.60
1.1
1.1
mmol/l
7.0
6.5
—
8
51
(3009015) Lactate [Moles/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
7.1
—
0
12
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
141
0.64
0.60
1.1
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
47
391
1.21
0.58
3.9
3.4
kpa
8.4
7.8
1.45
42
352
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
343
0.78
0.58
2.7
3.7
mg/l
38.7
29.7
0.67
20
227
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
237
1.27
0.58
1.3
1.4
nmol/l
0.7
0.9
0.86
24
192
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
53
1.51
0.58
1.4
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
62
530
1.18
0.58
3.9
2.9
g/l
0.2
0.3
0.77
44
211
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
55
1.46
0.56
9.1
6.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
13
90
1.45
0.55
1.2
1.1
%
98.9
96.5
0.14
13
85
(21494434) Karyotype in Bone marrow
21
159
1.32
0.55
1.2
1.2
—
—
—
0
0
(44806420)
9
62
1.45
0.53
3.2
2.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
207
1922
1.09
0.52
2.7
2.4
%
2.1
1.8
2.11
185
1686
(3042631) Mycobacterium sp identified in Specimen
28
223
1.26
0.52
2.6
2.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9
63
1.43
0.52
2.1
2.1
e9/l
0.2
0.2
—
9
56
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
126
1.35
0.51
1.3
1.3
nmol/l
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
109
1.38
0.51
2.2
3.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
516
4964
1.06
0.48
3.4
2.8
ug/l
229.3
163.9
3.30
471
4459
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
119
1.35
0.48
1.3
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
120
0.67
0.45
1.0
1.2
—
92.8
—
0
7
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
73
649
1.13
0.44
1.7
1.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
31
1.61
0.43
2.2
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
330
3146
1.06
0.42
4.3
3.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.3
—
1036.3
—
0
5
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.2
—
0.9
—
0
10
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
86
950
0.90
0.41
1.3
1.5
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
17
0.00
0.40
0.0
2.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
230.2
—
0
11
(3012516) Albumin [Mass/volume] in Urine
399
4151
0.95
0.40
3.2
3.2
mg/l
483.3
279.4
0.38
269
2739
(3026470) Cobalt [Mass/volume] in Blood
7
104
0.67
0.39
1.4
2.1
ug/l
1.9
3.0
—
7
90
(3017704) Immunofixation for Urine
7
105
0.67
0.39
1.0
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
484
0.86
0.38
1.1
1.2
iu/ml
235.4
158.8
—
10
178
(3048689) Calprotectin [Mass/mass] in Stool
117
1078
1.09
0.38
2.9
2.2
ug/g
270.0
164.5
0.93
91
847
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
13.6
17.0
nmol/l
1869.2
1601.9
—
5
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
323
0.83
0.38
1.8
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
114
0.70
0.37
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
878
8605
1.04
0.37
5.1
4.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
217
1.20
0.35
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
110
1189
0.92
0.35
3.6
3.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
117
1.28
0.35
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
163
1.23
0.34
1.7
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
82
1.34
0.34
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
45
1.33
0.33
6.2
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
64
577
1.11
0.33
2.3
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
109
1.29
0.33
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
86
0.70
0.33
2.3
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
89
0.67
0.33
2.7
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
313
1.15
0.32
1.4
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
137
1.24
0.32
1.3
1.3
nmol/l
1.5
0.6
0.44
17
128
(3027008) Opiates [Presence] in Urine
7
96
0.73
0.31
2.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
96
0.73
0.31
2.1
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
97
0.72
0.31
1.9
2.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
99
0.71
0.30
1.0
1.4
—
66.0
—
0
10
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
546
0.89
0.30
3.0
3.4
mg/l
32.7
77.9
1.19
36
454
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
299
3105
0.95
0.29
1.7
1.8
pmol/l
453.1
16382810.2
1.66
236
2521
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.1
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
545
0.90
0.29
3.0
3.4
mg/l
52.3
65.5
0.45
35
450
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
48
534
0.90
0.29
3.0
3.3
ratio
4.1
1.5
—
5
45
(4306422)
15
121
1.24
0.28
1.5
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
112
1.25
0.28
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
136
1282
1.07
0.28
1.7
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
108
1011
1.07
0.27
3.7
3.9
ph
7.4
7.4
—
9
114
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
152
1440
1.06
0.27
2.2
2.6
ug/l
5.3
6.6
0.49
132
1242
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
103
963
1.07
0.27
3.8
3.9
mmol/l
1.3
2.0
0.86
68
708
(3019225) pH of Specimen
147
1392
1.06
0.27
4.1
4.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
67
1.19
0.26
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
213
0.84
0.25
1.1
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
169
0.83
0.24
1.9
2.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
52
475
1.10
0.24
1.3
1.8
u/l
43.8
38.0
0.94
40
410
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.1
—
18.4
—
0
7
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
179
0.84
0.23
3.9
4.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
221
0.86
0.22
1.4
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
40
1.25
0.22
2.2
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
94
0.74
0.22
2.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
94
0.74
0.22
2.1
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
294
0.88
0.21
1.8
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
42
1.19
0.21
1.6
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
103
0.78
0.21
1.0
1.4
—
261.4
—
0
14
(3004588) Protein electrophoresis panel - Serum or Plasma
108
1139
0.94
0.21
1.7
2.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
5.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
123
0.81
0.20
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
4840.2
—
0
9
(40757373) Influenza virus identified in Isolate
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
49
1.23
0.20
1.3
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
9
113
0.80
0.20
1.0
1.4
—
—
—
0
0
(4146454)
18
155
1.16
0.20
2.7
2.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
193
1.14
0.19
2.4
2.4
mg/l
37.3
23.7
—
6
43
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
127
1.18
0.19
1.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
110
1046
1.06
0.19
3.2
3.8
ng/l
86.4
99.8
1.25
100
888
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
48
443
1.09
0.19
1.6
2.6
g/l
0.0
0.0
0.00
37
401
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
81
1.24
0.18
2.0
1.2
promille
1.1
1.1
—
10
61
(3021901) Oxygen saturation in Capillary blood
35
319
1.10
0.18
2.7
3.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
71
1.13
0.16
1.1
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
79
0.76
0.15
2.0
2.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
78
1.15
0.15
1.3
1.1
mmol/l
2.3
2.0
—
9
72
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
107
1026
1.05
0.15
3.8
3.9
kpa
4.9
5.2
3.81
96
940
(3016879) Cocaine [Presence] in Urine
7
90
0.78
0.14
2.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
78
744
1.05
0.14
3.9
4.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
34
367
0.92
0.14
1.4
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
317
3109
1.02
0.13
1.8
1.8
nmol/l
1212.6
1174.8
0.29
248
2328
(3023410) Appearance of Cerebral spinal fluid
9
106
0.85
0.13
1.6
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
50
472
1.06
0.12
1.6
2.6
g/l
0.1
0.0
0.16
39
428
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51
538
0.95
0.12
1.6
2.7
g/l
0.7
1.5
0.90
40
457
(3029937) Albumin [Presence] in Urine by Test strip
329
3343
0.98
0.11
4.9
4.3
estimate
0.0
0.0
0.50
108
1050
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
594
1.05
0.10
1.5
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
46
437
1.05
0.10
1.7
2.6
g/l
0.0
0.0
0.00
36
400
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3013512) EKG study
405
4097
0.98
0.09
4.2
4.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
81
785
1.03
0.08
4.0
3.3
e9/l
4.8
4.2
0.61
66
566
(1617658) Protocol used for examination of sentinel lymph nodes
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
64
1.09
0.08
1.0
1.1
nmol/l
117.7
136.1
—
7
64
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
74
0.81
0.07
2.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
215
1.07
0.07
6.3
3.3
—
—
—
0
0
(3000012) Reticulocyte production index
8
75
1.07
0.07
1.1
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
78
1.03
0.07
2.3
1.6
—
73.4
—
0
5
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
63
610
1.03
0.07
4.3
4.2
mmol/l
24.4
24.9
0.74
58
564
(3023420) DNA double strand Ab [Units/volume] in Serum
8
90
0.89
0.06
1.0
1.3
—
35.3
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
109
1.10
0.06
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
284
0.95
0.06
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
42
435
0.96
0.05
1.5
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
110
1.09
0.05
4.4
3.0
%
11.8
10.9
0.39
12
110
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
636
0.97
0.05
1.7
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
635
0.98
0.04
1.7
2.6
g/l
4.1
3.9
0.56
41
455
(3000330) Specific gravity of Urine by Test strip
76
745
1.02
0.04
4.2
3.9
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
131
1.07
0.03
1.7
2.0
u/field
2.4
2.1
—
5
43
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
49
501
0.98
0.03
1.6
2.5
g/l
35.8
36.7
0.51
39
423
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
591
0.98
0.02
1.8
2.6
g/l
3.1
3.2
0.12
41
464
(3021589) Normoblasts [#/volume] in Blood
521
5228
1.00
0.02
23.4
10.4
e9/l
0.0
0.0
0.10
418
4238
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
459
4605
1.00
0.02
4.7
4.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
144
1429
1.01
0.02
2.9
2.6
e9/l
79.1
68.0
1.83
112
1126
(42529406) Shigella sp [Presence] in Stool by Culture
33
338
0.98
0.01
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
442
4408
1.00
0.01
4.1
3.9
mg/mmol
11.0
9.5
0.31
289
2876
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
34
333
1.02
0.01
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
352
3511
1.00
0.01
4.0
2.9
umol/l
4854.0
7731.9
0.52
303
2947
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
637
0.99
0.01
1.7
2.6
g/l
7.2
7.4
0.34
41
470
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
224
1.03
0.00
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
420
4193
1.00
0.00
3.3
3.1
mmol/l
7.3
7.5
0.32
321
3451
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
195
0.97
0.00
1.4
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
205
1.02
0.00
1.6
2.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
141
0.99
0.00
1.4
1.4
u/l
16.1
13.8
0.63
14
131
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
415
0.99
0.00
1.3
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
44
441
1.00
0.00
3.0
3.4
mmol/l
22.7
24.9
2.23
37
374
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
336
1.01
0.00
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
41
406
1.01
0.00
3.0
3.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
54
536
1.01
0.00
3.9
3.2
pmol/l
4.0
4.3
1.34
44
463
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
598
1.00
0.00
1.5
2.6
g/l
12.4
10.7
1.03
45
505
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
30
303
0.99
0.00
1.3
1.3
g/l
0.2
0.2
0.09
24
290
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
84
0.95
0.00
1.8
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
84
0.95
0.00
1.8
1.4
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
39.4
—
0
7
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
62
0.97
0.00
1.5
3.8
u/l
262.3
221.1
—
6
62
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
88
0.91
0.00
18.6
15.8
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
4.7
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
525.8
—
0
6
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
366.0
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
7.3
—
0
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
330
1.00
0.00
2.2
2.3
g/l
114.8
127.2
2.12
21
242
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
83
0.96
0.00
1.1
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
87
0.92
0.00
4.9
3.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
20.9
—
0
7
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
31.3
—
0
8
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_GALLBLADDER – Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).